Putting a Common Sleep Disorder to Bed
Millions of Americans suffer from sleep apnea, a disorder in which the patient repeatedly stops breathing during sleep.
Articles by vanderson
Pharmaceutical Companies Eye India
On May 21, Abbott Laboratories announced that it would purchase Piramal Healthcare, a branded generics company based in India, for $3.72 billion.
Not a Drop to Drink
As we brush our teeth, take our long showers, and drink our eight glasses a day, it’s easy to forget that nearly one billion people in the world don’t have access to clean water.
The Latest Cardiology News
Cameron Health has released positive clinical trial data on a unique therapy to prevent sudden cardiac arrest, a leading cause of death in the U.S.
[Company Profile] Altea Therapeutics
One of the more impressive companies at the IN3 West conference was Altea Therapeutics, an Atlanta-based clinical stage company involved in drug delivery.
IN3 East Is Almost Here
Join us next month at IN3 East 2010 in Boston, aimed at partnering a global audience of VCs, top investors, and corporate acquirers with early-/mid-/late-stage, medical technology start-ups and revolutionary innovators.
New National Drug Abuse Strategy Emphasizes Prevention
On May 11, the Obama administration unveiled its 2010 National Drug Control Strategy to reduce illicit drug use in America.
[Company Profile] NeoVista
The company is focused on the development of medical technologies that to treat wet age-related macular degeneration (AMD).
Valuable Take-Aways From IN3 West
IN3 West held an investor conference in Las Vegas with the title of “Investment in Innovation.” IN3 Conferences take place around the country and are developed by Elsevier Business Intelligence, which publishes the highly regarded industry report In Vivo.
FDA Hopes to Keep Pharma Honest With “Bad Ad” Program
Last week, the FDA unveiled its “Bad Ad” program to encourage physicians to report questionable pharmaceutical sales pitches.